Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Hepatitis B
Pertussis
Varicella
All age groups
Western Pacific
Clear all
Type of publications
Systematic reviews (SYSVAC)
(6)
Topics
Available to download in languages
Regions
Western Pacific
(6)
Africa
(2)
Americas
(2)
Eastern Mediterranean
(3)
Europe
(8)
Countries
Australia
(1)
China
(3)
Diseases
Hepatitis B
(3)
Pertussis
(2)
Varicella
(1)
COVID-19
(14)
Haemophilus influenzae type B
(1)
Hepatitis A
(1)
Human papillomavirus (HPV)
(2)
Influenza
(3)
Mumps
(1)
Pneumococcal disease
(4)
Poliomyelitis
(1)
Rabies
(1)
Rotavirus
(1)
Vaccine topics
Coverage
(3)
Economic aspects
(1)
Efficacy/effectiveness
(2)
Ethical issues
(1)
Target population
All age groups
(6)
Adolescents
(1)
Adults
(1)
Children
(1)
Healthcare workers
(1)
Newborn
(1)
Older adults
(1)
Parents/caregivers
(1)
Pregnant women
(2)
Publication date
2022
(1)
2021
(2)
2019
(1)
2017
(1)
2012
(1)
6 results found
2022
∙
Bai, X. Chen, L. Liu, X. Tong, Y. Wang, L. Zhou, M. Li, Y. Hu, G.
Adult Hepatitis B Virus Vaccination Coverage in China from 2011 to 2021: A Systematic Review
2021
∙
Mungall, B. A. Kim, H. Oh, K. B.
A systematic review of the burden of pertussis in South Korea
2021
∙
Macina, D. Evans, K. E.
Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in Asia
2019
∙
Graham, S. MacLachlan, J. H. Gunaratnam, P. Cowie, B. C.
Chronic hepatitis B prevalence in Australian Aboriginal and Torres Strait Islander people before and after implementing a universal vaccination program: a systematic review and meta-analysis
2017
∙
Wong, C. K. H. Liao, Q. Guo, V. Y. W. Xin, Y. Lam, C. L. K.
Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review
2012
∙
Liu, Hui Ma, YongLei Wang, HongFei Liu, QiGui
Quantitative evaluation of the effect of the hepatitis B vaccine based on the HBsAg- and anti-HBs-positive rates in the Chinese population over the last 33 years
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register